Moderna (MRNA) Change in Acquisitions & Divestments (2018 - 2026)

Moderna (MRNA) has reported Change in Acquisitions & Divestments for 9 consecutive years, with $710.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 52.38% year-over-year to $710.0 million in Q2 2026; TTM through Jun 2026 was $3.6 billion, a 34.29% decrease from a year earlier, with the FY2025 full-year figure at $5.6 billion, changed 0.02% from the prior year.
• Change in Acquisitions & Divestments was $710.0 million for Q2 2026 at Moderna, down from $732.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $2.0 billion in Q2 2024 and troughed at $412.0 million in Q3 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 306.19% in 2022 and plunged 62.13% in 2026, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $630.0 million in 2022, then soared by 37.14% to $864.0 million in 2023, then gained by 5.79% to $914.0 million in 2024, then climbed by 1.64% to $929.0 million in 2025, then declined by 23.57% to $710.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $710.0 million (Q2 2026), $732.0 million (Q1 2026), and $929.0 million (Q4 2025), per Business Quant data.